OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.725
-0.045 (-2.54%)
Nov 20, 2024, 4:00 PM EST - Market closed
OS Therapies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cost of Revenue | 0.01 | 0.01 | 0 | 1.16 | 4.25 |
| Gross Profit | -0.01 | -0.01 | -0 | -1.16 | -4.25 |
| Selling, General & Admin | 2.01 | 1.12 | 1.15 | 1.5 | 0.8 |
| Research & Development | 2.99 | 3.22 | 3.29 | 2.17 | 0.6 |
| Operating Expenses | 5 | 4.34 | 4.45 | 3.68 | 1.4 |
| Operating Income | -5 | -4.34 | -4.45 | -4.84 | -5.65 |
| Interest Expense | -2.35 | -3.45 | -1.81 | -2.58 | -0.46 |
| Interest & Investment Income | 0 | 0 | - | - | 0.06 |
| Other Non Operating Income (Expenses) | - | - | - | - | 0.02 |
| Pretax Income | -7.36 | -7.79 | -6.25 | -7.42 | -6.03 |
| Net Income | -7.36 | -7.79 | -6.25 | -7.42 | -6.03 |
| Preferred Dividends & Other Adjustments | 0.06 | 0.13 | 0.13 | 0.09 | - |
| Net Income to Common | -7.42 | -7.92 | -6.38 | -7.51 | -6.03 |
| Shares Outstanding (Basic) | 10 | 11 | 10 | 10 | 8 |
| Shares Outstanding (Diluted) | 10 | 11 | 10 | 10 | 8 |
| Shares Change (YoY) | -6.42% | 7.01% | - | 18.50% | - |
| EPS (Basic) | -0.76 | -0.74 | -0.64 | -0.75 | -0.72 |
| EPS (Diluted) | -0.76 | -0.74 | -0.64 | -0.75 | -0.72 |
| Free Cash Flow | -5.78 | -3.01 | -3.79 | -4.41 | -2.42 |
| Free Cash Flow Per Share | -0.59 | -0.28 | -0.38 | -0.44 | -0.29 |
| EBITDA | -5 | -4.34 | -4.45 | -4.84 | -5.65 |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 |
| EBIT | -5 | -4.34 | -4.45 | -4.84 | -5.65 |
Source: S&P Capital IQ. Standard template.
Financial Sources.